Short revision bullets only, not a replacement for the full lesson sections below.
Toggle for a short revision list before a mock or question block.
Pathophysiology
Clinical Framing
Metformin remains the foundational agent for T2DM, but >50% of patients require intensification within 3 years. The NP's challenge at intensification is not just picking an antihyperglycemic — it is selecting the agent that simultaneously treats the most important comorbidity risk. GLP-1 receptor agonists and SGLT-2 inhibitors have transformed T2DM management by offering cardiovascular and renal protection independent of A1c lowering. Knowing when and how to prescribe these agents, including dosing, monitoring, and contraindications, is now core NP competency.
Population Considerations
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Core Concepts & Differential
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Management Approach
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Follow-Up & Monitoring
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
We didn’t match sample stems to this lesson in the bank yet. You can still run a topic-scoped drill with the same pathway filters—items load from your live FNP pool.
